Stockreport

Truist Highlights Nuvation Bio's (NUVB) Ibtrozi's Robust Market Uptake and Lead Over Competitors [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF target on Nuvation Bio to $13 from $11 and maintained a Buy rating, citing the Ibtrozi franchise's robust initial performance as part of a Q4 2025 earnings preview for t [Read more]